TY - JOUR
T1 - Retinoic acid enhancement of an early step in the transformation of mouse epidermal cells in vitro
AU - Kulesz-Martin, Molly
AU - Blumenson, Leslie
AU - Lisafeld, Barbara
N1 - Funding Information:
We wish to thank Dr Remidios Penetrante, Department of Pathology, RPMI for evaluation of tumors, Dr Henry Hennings, National Cancer Institute for determinations of Ca2+ in culture medium, and Ms Deborah Driscoll for help in statistical analysis. The secretarial assistance of Ms Mac Brown and technical assistance of Ms JoEDen Budnick are also gratelulry acknowledged. This investigation was supported by PHS Grants CA 31101 and CA 24538 from the National Cancer Institute, DHHS, USA. A preliminary report of these results was presented at the meeting of the American Association for Cancer Research, May 1985, Houston, TX (1).
PY - 1986/9
Y1 - 1986/9
N2 - Retinoic acid has been reported to act as an inhibitor and as an enhancer of mouse skin carcinogenesis in vivo. However, no in vitro cell transformation model has been reported to be sensitive to both effects. In an attempt to provide such a model, the effect of retinoic acid on an early step in carcinogen-induced transformation of mouse epidermal cell line 271c was measured using a recently described assay. The step observed is altered response to extracellular Ca2+ as an epidermal terminal differentiation signal. In six out of twelve experiments retinoic acid increased the frequency of altered colonies resulting from treatment with three chemical carcinogens. The enhancement effect was stronger after DMBA treatment than MNNG or MCA, resulting in up to a 13.7-fold increase in the frequency of colonies exhibiting altered terminal differentiation (TF). On the other hand, up to a 10-fold decrease in TF was observed in other experiments. Both the enhancement and inhibitory effects were greater at the higher doses of retinoic acid tested in the range of 10-10-10-7 M. Variations in cloning efficiency or surviving colony density did not account for the effects on TF. Enhancement effects tended to be observed at lower doses of carcinogen, or in experiments in which TF resulting from treatment with carcinogen alone was in the lower range observed. However, the factors determining each effect have yet to be defined. The enhancement effect of retinoic acid was not merely suppression of the phenotypic endpoint of the in vitro assays, because treatment of carcinogen-altered cells with retinoic add or TPA in vitro also enhanced their tumorigenicity in vivo compared to acetone conrols. These findings suggest that studies of the determinants of retinoid activity should be a prerequisite to their use in chemoprevention.
AB - Retinoic acid has been reported to act as an inhibitor and as an enhancer of mouse skin carcinogenesis in vivo. However, no in vitro cell transformation model has been reported to be sensitive to both effects. In an attempt to provide such a model, the effect of retinoic acid on an early step in carcinogen-induced transformation of mouse epidermal cell line 271c was measured using a recently described assay. The step observed is altered response to extracellular Ca2+ as an epidermal terminal differentiation signal. In six out of twelve experiments retinoic acid increased the frequency of altered colonies resulting from treatment with three chemical carcinogens. The enhancement effect was stronger after DMBA treatment than MNNG or MCA, resulting in up to a 13.7-fold increase in the frequency of colonies exhibiting altered terminal differentiation (TF). On the other hand, up to a 10-fold decrease in TF was observed in other experiments. Both the enhancement and inhibitory effects were greater at the higher doses of retinoic acid tested in the range of 10-10-10-7 M. Variations in cloning efficiency or surviving colony density did not account for the effects on TF. Enhancement effects tended to be observed at lower doses of carcinogen, or in experiments in which TF resulting from treatment with carcinogen alone was in the lower range observed. However, the factors determining each effect have yet to be defined. The enhancement effect of retinoic acid was not merely suppression of the phenotypic endpoint of the in vitro assays, because treatment of carcinogen-altered cells with retinoic add or TPA in vitro also enhanced their tumorigenicity in vivo compared to acetone conrols. These findings suggest that studies of the determinants of retinoid activity should be a prerequisite to their use in chemoprevention.
UR - http://www.scopus.com/inward/record.url?scp=0022779695&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022779695&partnerID=8YFLogxK
U2 - 10.1093/carcin/7.9.1425
DO - 10.1093/carcin/7.9.1425
M3 - Article
C2 - 3091282
AN - SCOPUS:0022779695
SN - 0143-3334
VL - 7
SP - 1425
EP - 1429
JO - Carcinogenesis
JF - Carcinogenesis
IS - 9
ER -